Brain Cancer Diagnostics Market to Register Immense Growth at a CAGR of ~10% by 2034 | DelveInsight
The global brain cancer diagnostics market, valued at USD 4.10 billion in 2025, is expected to grow at a CAGR of 10.2% to reach USD 9.85 billion by 2034. Growth is driven by rising brain tumor incidence, advanced neuroimaging technologies, and molecular diagnostics adoption. Imaging diagnostics leads with 46% market share, while glioblastoma represents 41% by tumor type. North America dominates with 45% revenue share, with Asia-Pacific showing fastest growth potential.
